These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


882 related items for PubMed ID: 16489740

  • 1. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL, Lockhart E, Warren ME, Lenkowski A, Wilhelm SE, Hoffman M.
    Biochemistry; 2006 Feb 28; 45(8):2480-7. PubMed ID: 16489740
    [Abstract] [Full Text] [Related]

  • 2. Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin.
    Sauls DL, Warren M, Hoffman M.
    Thromb Res; 2011 Jun 28; 127(6):576-81. PubMed ID: 21316742
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H.
    Arterioscler Thromb Vasc Biol; 2006 Jun 28; 26(6):1397-404. PubMed ID: 16574890
    [Abstract] [Full Text] [Related]

  • 5. Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
    Malinowska J, Babicz K, Olas B, Stochmal A, Oleszek W.
    Nutrition; 2012 Jul 28; 28(7-8):793-8. PubMed ID: 22261575
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH, Lee HJ, Lee EK, Yu HK, Lee TH, Yoon Y, Kim SJ, Kim JS.
    Biol Chem; 2011 Apr 28; 392(4):347-56. PubMed ID: 21194375
    [Abstract] [Full Text] [Related]

  • 14. [Importance of the structure of the clot in thrombolysis].
    Soria C, Soria J, Mirshahi M, Desvignes P, Bonnet P, Caen JP.
    Ann Biol Clin (Paris); 1987 Apr 28; 45(2):207-11. PubMed ID: 2441630
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH, Diamond SL.
    Thromb Haemost; 1995 Aug 28; 74(2):711-7. PubMed ID: 8585011
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of resveratrol on hemostatic properties of human fibrinogen and plasma during model of hyperhomocysteinemia.
    Malinowska J, Olas B.
    Thromb Res; 2010 Nov 28; 126(5):e379-82. PubMed ID: 20869101
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 45.